Concomitant Temozolomide plus radiotherapy for high-grade and recurrent meningioma: a retrospective chart review. Belanger K, Ung TH, Damek D, Lillehei KO, et al. BMC Cancer 2022;22:367.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Belanger K, Ung TH, Damek D, Lillehei KO, et al. Concomitant Temozolomide plus radiotherapy for high-grade and recurrent meningioma: a retrospective chart review. BMC Cancer 2022;22:367.
PMID: 35392834